| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | PHACTR2 AKAP5 ANK3 MYO1E CENPE CENPF PACSIN1 IFT74 DBN1 SHTN1 ARPC4 MPRIP BLOC1S6 BRCA1 PHACTR4 DIAPH1 DLG4 MTUS2 NLRP5 PHACTR1 | 2.25e-05 | 1099 | 128 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 4.08e-05 | 2 | 128 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 4.08e-05 | 2 | 128 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 4.08e-05 | 2 | 128 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 4.08e-05 | 2 | 128 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 1.11e-04 | 15 | 128 | 3 | GO:0016725 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 2.43e-04 | 4 | 128 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 2.43e-04 | 4 | 128 | 2 | GO:0071614 | |
| GeneOntologyMolecularFunction | actin binding | PHACTR2 AKAP5 MYO1E DBN1 SHTN1 ARPC4 MPRIP BLOC1S6 PHACTR4 DIAPH1 PHACTR1 | 2.64e-04 | 479 | 128 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 4.03e-04 | 5 | 128 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 4.03e-04 | 5 | 128 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 4.03e-04 | 5 | 128 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 5.23e-04 | 58 | 128 | 4 | GO:0051018 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 5.34e-04 | 25 | 128 | 3 | GO:0034237 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 1.11e-03 | 8 | 128 | 2 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 1.11e-03 | 8 | 128 | 2 | GO:0034875 | |
| GeneOntologyMolecularFunction | carbonyl reductase (NADPH) activity | 1.43e-03 | 9 | 128 | 2 | GO:0004090 | |
| GeneOntologyMolecularFunction | beta-2 adrenergic receptor binding | 1.77e-03 | 10 | 128 | 2 | GO:0031698 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 2.16e-03 | 11 | 128 | 2 | GO:0101020 | |
| GeneOntologyBiologicalProcess | actin filament-based process | PHACTR2 MYL6 MYO1E PACSIN1 SH3BP1 ABCC9 DBN1 ARHGAP35 SHTN1 PIP5K1C ARPC4 NUAK2 BLOC1S6 FAT1 AKAP9 PHACTR4 DIAPH1 CGNL1 NLRP5 PHACTR1 | 5.11e-07 | 912 | 124 | 20 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | PHACTR2 MYO1E PACSIN1 SH3BP1 DBN1 ARHGAP35 SHTN1 PIP5K1C ARPC4 NUAK2 BLOC1S6 FAT1 PHACTR4 DIAPH1 CGNL1 NLRP5 PHACTR1 | 6.39e-06 | 803 | 124 | 17 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin filament organization | MYO1E PACSIN1 SH3BP1 DBN1 ARHGAP35 SHTN1 ARPC4 BLOC1S6 FAT1 DIAPH1 CGNL1 NLRP5 PHACTR1 | 1.22e-05 | 509 | 124 | 13 | GO:0007015 |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 4.74e-05 | 278 | 124 | 9 | GO:0031503 | |
| GeneOntologyCellularComponent | cell leading edge | AKAP5 PACSIN1 SH3BP1 DBN1 SAMSN1 SHTN1 PIP5K1C BLOC1S6 FAT1 STX3 PHACTR4 DIAPH1 | 4.69e-05 | 500 | 125 | 12 | GO:0031252 |
| Domain | RPEL | 8.88e-06 | 7 | 120 | 3 | PS51073 | |
| Domain | RPEL | 8.88e-06 | 7 | 120 | 3 | SM00707 | |
| Domain | RPEL | 8.88e-06 | 7 | 120 | 3 | PF02755 | |
| Domain | RPEL_repeat | 8.88e-06 | 7 | 120 | 3 | IPR004018 | |
| Domain | Pkinase-A_anch_WSK-motif | 4.09e-05 | 2 | 120 | 2 | IPR001573 | |
| Domain | WSK | 4.09e-05 | 2 | 120 | 2 | PF03832 | |
| Domain | AKAP95 | 1.22e-04 | 3 | 120 | 2 | PF04988 | |
| Domain | AKAP95 | 1.22e-04 | 3 | 120 | 2 | IPR007071 | |
| Domain | ZF_C2H2_AKAP95 | 1.22e-04 | 3 | 120 | 2 | PS51799 | |
| Domain | - | 1.24e-04 | 40 | 120 | 4 | 3.40.630.30 | |
| Domain | Acyl_CoA_acyltransferase | 1.97e-04 | 45 | 120 | 4 | IPR016181 | |
| Domain | FF_domain | 6.04e-04 | 6 | 120 | 2 | IPR002713 | |
| Domain | FF | 6.04e-04 | 6 | 120 | 2 | PS51676 | |
| Domain | FF | 6.04e-04 | 6 | 120 | 2 | PF01846 | |
| Domain | FF | 6.04e-04 | 6 | 120 | 2 | SM00441 | |
| Domain | Pept_M16_Zn_BS | 8.42e-04 | 7 | 120 | 2 | IPR001431 | |
| Domain | Pept_M16_dom | 8.42e-04 | 7 | 120 | 2 | IPR011237 | |
| Domain | Metalloenz_LuxS/M16 | 8.42e-04 | 7 | 120 | 2 | IPR011249 | |
| Domain | Peptidase_M16 | 8.42e-04 | 7 | 120 | 2 | PF00675 | |
| Domain | Peptidase_M16_C | 8.42e-04 | 7 | 120 | 2 | IPR007863 | |
| Domain | Peptidase_M16_C | 8.42e-04 | 7 | 120 | 2 | PF05193 | |
| Domain | Pept_M16_N | 8.42e-04 | 7 | 120 | 2 | IPR011765 | |
| Domain | - | 8.42e-04 | 7 | 120 | 2 | 3.30.830.10 | |
| Domain | INSULINASE | 8.42e-04 | 7 | 120 | 2 | PS00143 | |
| Domain | Cation/H_exchanger_CPA1 | 2.17e-03 | 11 | 120 | 2 | IPR018422 | |
| Domain | Na_H_Exchanger | 3.54e-03 | 14 | 120 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 3.54e-03 | 14 | 120 | 2 | IPR006153 | |
| Domain | A/G_cyclase_CS | 5.23e-03 | 17 | 120 | 2 | IPR018297 | |
| Domain | UIM | 5.86e-03 | 18 | 120 | 2 | PF02809 | |
| Domain | ZF_ZZ_2 | 5.86e-03 | 18 | 120 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 5.86e-03 | 18 | 120 | 2 | PS01357 | |
| Domain | - | 5.86e-03 | 18 | 120 | 2 | 3.30.70.1230 | |
| Domain | ZZ | 5.86e-03 | 18 | 120 | 2 | PF00569 | |
| Domain | Nucleotide_cyclase | 5.86e-03 | 18 | 120 | 2 | IPR029787 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GRIPAP1 MYL6 MYO1E MAT2B PSMA5 RCN2 SMC4 PSMC5 PTPN23 IDE RRM1 SHTN1 ARPC4 HNRNPD AKAP12 IGF2BP3 MTA3 UBE2H PHACTR4 DIAPH1 USP7 HSP90AB2P OGA NMT1 HSPA9 | 1.12e-10 | 1455 | 128 | 25 | 22863883 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MYL6 PSMC5 PTPN23 TFIP11 DBN1 ARHGAP35 SHTN1 PRPF40A AKAP12 MPRIP IGF2BP3 UBAP2L USP7 CGNL1 OGA NMT1 CPSF3 HSPA9 RSBN1L KNL1 | 2.42e-10 | 934 | 128 | 20 | 33916271 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ZNF326 MYL6 PITRM1 DNAH10 MAT2B CENPF VPS13C RGS22 PSMA5 RCN2 SMC4 PSMC5 IDE DBN1 PRPF40A HNRNPD HNRNPH3 UBAP2L DIAPH1 USP7 UTP20 CPSF3 HSPA9 GOLGA4 | 4.18e-10 | 1425 | 128 | 24 | 30948266 |
| Pubmed | PHACTR2 MYL6 CENPF PSMC5 TFIP11 DBN1 ARHGAP35 SHTN1 PRPF40A ARPC4 HNRNPD MPRIP PHACTR4 DIAPH1 USP7 | 6.62e-10 | 506 | 128 | 15 | 30890647 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | KRT5 MYL6 ANK3 PSMA5 RCN2 SMC4 PSMC5 DBN1 SHTN1 PRPF40A HNRNPD AKAP8L AKAP12 NEFL IGF2BP3 UBAP2L DIAPH1 USP7 OGA NMT1 HSPA9 | 1.42e-09 | 1149 | 128 | 21 | 35446349 |
| Pubmed | ZNF326 CENPF PSMA5 PSMC5 HNRNPD HNRNPH3 AKAP12 IGF2BP3 BRCA1 UBAP2L DIAPH1 USP7 HSP90AB2P HSPA9 | 4.50e-09 | 494 | 128 | 14 | 26831064 | |
| Pubmed | ANK3 ICE2 RCN2 SMC4 PSMC5 PTPN23 RRM1 SHTN1 PRPF40A HNRNPD ADCY9 AKAP12 UBAP2L PHACTR4 HSPA9 GOLGA4 | 8.30e-09 | 708 | 128 | 16 | 39231216 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KRT5 MYL6 MYO1E MAT2B PSMA5 SMC4 PTPN23 TFIP11 ARHGAP35 RRM1 ARPC4 HNRNPD HNRNPH3 IGF2BP3 UBE2H UBAP2L DIAPH1 USP7 HSP90AB2P NMT1 HSPA9 GOLGA4 | 1.05e-08 | 1415 | 128 | 22 | 28515276 |
| Pubmed | GRIPAP1 CENPE VPS13C ICE2 RCN2 PSMC5 TFIP11 ZDBF2 ADCY9 ITPR2 GLE1 DIAPH1 CPSF3 RSBN1L GOLGA4 KNL1 | 1.35e-08 | 733 | 128 | 16 | 34672954 | |
| Pubmed | ANK3 IFT74 SMC4 PTPN23 TFIP11 DBN1 ARHGAP35 SHTN1 PRPF40A MPRIP UBAP2L PHACTR4 USP7 RSBN1L | 1.70e-08 | 549 | 128 | 14 | 38280479 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | ZNF326 MYL6 CENPF PSMA5 PSMC5 TFIP11 PRPF40A HNRNPD AKAP8L HNRNPH3 USP7 UTP20 HSP90AB2P USP27X CPSF3 HSPA9 RSBN1L KNL1 | 2.55e-08 | 989 | 128 | 18 | 36424410 |
| Pubmed | KRT5 GRIPAP1 ZNF326 MYL6 ANK3 VPS13C PSMA5 ADCY9 AKAP12 IGF2BP3 FAT1 BRCA1 PHACTR4 CGNL1 HSPA9 GOLGA4 | 3.02e-08 | 777 | 128 | 16 | 35844135 | |
| Pubmed | KRT5 ZNF326 MYL6 RCN2 PRPF40A HNRNPD AKAP8L HNRNPH3 IGF2BP3 UBAP2L HSP90AB2P HSPA9 | 5.68e-08 | 421 | 128 | 12 | 34650049 | |
| Pubmed | ZNF326 PITRM1 DNAH10 PSMA5 RCN2 PSMC5 TFIP11 KAT2A DBN1 PRPF40A ARPC4 AKAP8L HNRNPH3 MPRIP IGF2BP3 FAT1 MTA3 BRCA1 UBAP2L USP7 USP27X | 6.16e-08 | 1429 | 128 | 21 | 35140242 | |
| Pubmed | ANK3 CENPE CENPF SH3BP1 DBN1 SHTN1 ARPC4 AKAP12 MPRIP NEFL AKAP9 UBAP2L DIAPH1 DLG4 HSPA9 GOLGA4 PHACTR1 | 9.94e-08 | 963 | 128 | 17 | 28671696 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ZNF326 PSMA5 SMC4 PSMC5 PTPN23 TFIP11 RRM1 ARPC4 HNRNPD AKAP8L HNRNPH3 MPRIP DIAPH1 USP7 ANKIB1 UTP20 HSP90AB2P CPSF3 HSPA9 GOLGA4 | 1.20e-07 | 1353 | 128 | 20 | 29467282 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | GRIPAP1 IFT74 DTYMK PSMA5 SMC4 PSMC5 PTPN23 IDE RRM1 PRPF40A ARPC4 HNRNPD HNRNPH3 AKAP12 ANKRD13A UBAP2L NMT1 CPSF3 HSPA9 KNL1 | 1.42e-07 | 1367 | 128 | 20 | 32687490 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT5 ZNF326 MYL6 MYO1E CENPF RCN2 SMC4 DBN1 ARPC4 HNRNPD HNRNPH3 MPRIP ITPR2 MTA3 USP7 UTP20 NMT1 HSPA9 RSBN1L | 1.84e-07 | 1257 | 128 | 19 | 36526897 |
| Pubmed | 2.30e-07 | 114 | 128 | 7 | 31553912 | ||
| Pubmed | VSNL1 ANK3 MYO1E IFT74 PEG3 TFIP11 SHTN1 CBR3 AKAP8L MPRIP NEFL NSMF MTA3 SGSM2 USP7 DLG4 MTUS2 HSPA9 RSBN1L | 2.57e-07 | 1285 | 128 | 19 | 35914814 | |
| Pubmed | KRT5 MYL6 ANK3 MYO1E PACSIN1 DBN1 ARHGAP35 PRPF40A ARPC4 HNRNPD MPRIP ITPR2 NUAK2 NEFL UBAP2L USP7 DLG4 CGNL1 MTUS2 HSPA9 | 2.93e-07 | 1431 | 128 | 20 | 37142655 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CDR2 GRIPAP1 MYL6 ANK3 PITRM1 MYO1E IFT74 SMC4 PSMC5 ARPC4 AKAP12 MPRIP ANKRD13A NEFL SLC9C1 GPBP1L1 UBE2H HSP90AB2P NMT1 | 3.90e-07 | 1321 | 128 | 19 | 27173435 |
| Pubmed | Assembly of the WHIP-TRIM14-PPP6C Mitochondrial Complex Promotes RIG-I-Mediated Antiviral Signaling. | SMC4 DBN1 SHTN1 HNRNPD AKAP8L HNRNPH3 AKAP12 IGF2BP3 FAT1 OGA | 4.60e-07 | 332 | 128 | 10 | 29053956 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | KRT5 FAM184A GRIPAP1 ZNF326 MYL6 CENPE IFT74 VPS13C RCN2 PTPN23 HNRNPH3 PHACTR4 CGNL1 NMT1 HSPA9 | 6.25e-07 | 853 | 128 | 15 | 28718761 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 6.36e-07 | 344 | 128 | 10 | 30333137 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MROH9 DONSON PITRM1 SLC5A7 IDE DBN1 PIP5K1C ARPC4 ADCY9 ANKRD13A GPBP1L1 NSMF AKAP9 MTA3 GLE1 DLG4 PXYLP1 CPSF3 | 7.31e-07 | 1242 | 128 | 18 | 30973865 |
| Pubmed | GRIPAP1 ZNF326 MYL6 PITRM1 PSMA5 SMC4 PSMC5 ARPC4 NEFL DIAPH1 HSP90AB2P HSPA9 | 7.76e-07 | 538 | 128 | 12 | 28524877 | |
| Pubmed | DBN1 PRPF40A HNRNPD HNRNPH3 MPRIP IGF2BP3 UBAP2L CPSF3 HSPA9 | 8.63e-07 | 274 | 128 | 9 | 34244482 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | ZNF326 MYL6 MYO1E DBN1 PRPF40A MPRIP IGF2BP3 BRCA1 USP7 KNL1 | 9.83e-07 | 361 | 128 | 10 | 30344098 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PSMA5 TFIP11 DBN1 ARHGAP35 PRPF40A HNRNPD AKAP8L UBAP2L PHACTR4 USP7 UTP20 OGA NMT1 GOLGA4 | 1.09e-06 | 774 | 128 | 14 | 15302935 |
| Pubmed | KRT5 MYL6 PSMA5 RCN2 SMC4 PSMC5 DBN1 RRM1 PIP5K1C HNRNPD HNRNPH3 IGF2BP3 MTA3 UBAP2L HSP90AB2P HSPA9 NLRP5 | 1.21e-06 | 1153 | 128 | 17 | 29845934 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | KRT5 ZNF326 CENPF PSMA5 SMC4 PSMC5 PRPF40A HNRNPD HNRNPH3 ITPR2 NEFL IGF2BP3 UBAP2L GLE1 UTP20 HSPA9 | 1.21e-06 | 1024 | 128 | 16 | 24711643 |
| Pubmed | KRT5 AKAP5 ANK3 RCN2 PSMC5 PTPN23 IDE AKAP8L ADCY9 ITPR2 NEFL AKAP9 USP7 CPSF3 GOLGA4 KNL1 | 1.66e-06 | 1049 | 128 | 16 | 27880917 | |
| Pubmed | Phactrs 1-4: A family of protein phosphatase 1 and actin regulatory proteins. | 1.69e-06 | 7 | 128 | 3 | 15107502 | |
| Pubmed | Different expression patterns of Phactr family members in normal and injured mouse brain. | 1.69e-06 | 7 | 128 | 3 | 22766235 | |
| Pubmed | 1.92e-06 | 156 | 128 | 7 | 29961565 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KRT5 GRIPAP1 CENPE IFT74 ZDBF2 MPRIP IGF2BP3 GPBP1L1 DIAPH1 USP7 CGNL1 KNL1 | 1.95e-06 | 588 | 128 | 12 | 38580884 |
| Pubmed | 2.30e-06 | 397 | 128 | 10 | 21319273 | ||
| Pubmed | ZNF326 MYL6 TFIP11 DBN1 PRPF40A HNRNPD AKAP8L HNRNPH3 MPRIP IGF2BP3 NRBP2 CPSF3 RSBN1L | 2.48e-06 | 713 | 128 | 13 | 29802200 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | ZNF326 RCN2 DBN1 PRPF40A ARPC4 HNRNPD AKAP8L HNRNPH3 IGF2BP3 UBAP2L HSP90AB2P CPSF3 HSPA9 | 2.51e-06 | 714 | 128 | 13 | 28302793 |
| Pubmed | 2.66e-06 | 234 | 128 | 8 | 36243803 | ||
| Pubmed | Identification and characterization of human FNBP3 gene in silico. | 2.69e-06 | 8 | 128 | 3 | 12964049 | |
| Pubmed | MYL6 MYO1E MAT2B RCN2 DBN1 PRPF40A HNRNPH3 AKAP12 ITPR2 AKAP9 UBAP2L | 2.76e-06 | 503 | 128 | 11 | 36217030 | |
| Pubmed | KRT5 MYL6 PSMA5 RCN2 SMC4 PSMC5 RRM1 HNRNPD AKAP8L HNRNPH3 IGF2BP3 UBAP2L USP7 CPSF3 HSPA9 | 3.08e-06 | 971 | 128 | 15 | 33306668 | |
| Pubmed | ZNF326 MYL6 PSMA5 SMC4 TFIP11 DBN1 PRPF40A ARPC4 HNRNPD AKAP8L MPRIP IGF2BP3 UTP20 CPSF3 | 3.11e-06 | 847 | 128 | 14 | 35850772 | |
| Pubmed | Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology. | 3.52e-06 | 243 | 128 | 8 | 36964488 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | KRT5 MYL6 MYO1E RCN2 DBN1 ARPC4 MPRIP ITPR2 IGF2BP3 MTA3 UBAP2L HSPA9 | 3.71e-06 | 626 | 128 | 12 | 33644029 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | GRIPAP1 PITRM1 MYO1E MAT2B CENPF IDE CREG1 AKAP8L AKAP9 UBAP2L USP7 UTP20 CPSF3 | 4.54e-06 | 754 | 128 | 13 | 33060197 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYL6 PSMA5 RCN2 SMC4 PSMC5 DBN1 ARPC4 AKAP12 MPRIP ANKRD13A IGF2BP3 HSPA9 | 5.18e-06 | 647 | 128 | 12 | 26618866 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 5.72e-06 | 120 | 128 | 6 | 31413325 | |
| Pubmed | ZNF326 SMC4 PSMC5 DBN1 HNRNPD AKAP8L HNRNPH3 NEFL IGF2BP3 UBAP2L HSPA9 | 6.55e-06 | 551 | 128 | 11 | 34728620 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 6.82e-06 | 353 | 128 | 9 | 27545878 | |
| Pubmed | 6.91e-06 | 124 | 128 | 6 | 35516420 | ||
| Pubmed | 7.07e-06 | 451 | 128 | 10 | 36168627 | ||
| Pubmed | ZNF326 MAT2B PSMA5 SH3BP1 SMC4 ARHGAP35 PIP5K1C AKAP8L MPRIP NEFL UBAP2L USP7 CPSF3 GOLGA4 | 7.57e-06 | 916 | 128 | 14 | 32203420 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | ZNF326 MYL6 PSMA5 RCN2 PSMC5 AKAP8L IGF2BP3 USP7 HSP90AB2P CPSF3 HSPA9 | 8.29e-06 | 565 | 128 | 11 | 33567341 |
| Pubmed | FGF11 induced by hypoxia interacts with HIF-1α and enhances its stability. | 8.30e-06 | 128 | 128 | 6 | 28027390 | |
| Pubmed | ZNF326 MYL6 MAT2B IFT74 ICE2 PSMA5 PEG3 RCN2 PSMC5 ARPC4 HNRNPD AKAP8L HNRNPH3 IGF2BP3 USP7 HSP90AB2P HSPA9 | 8.50e-06 | 1335 | 128 | 17 | 29229926 | |
| Pubmed | FAM184A AKAP5 ANK3 MAT2B RCN2 TFIP11 RRM1 PRPF40A ADCY9 AKAP12 MPRIP ITPR2 AKAP9 PHACTR4 OGA HSPA9 GOLGA4 ATPAF1 | 8.99e-06 | 1487 | 128 | 18 | 33957083 | |
| Pubmed | 9.17e-06 | 277 | 128 | 8 | 30745168 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | KRT5 PITRM1 CENPE CENPF VPS13C PSMA5 PSMC5 ZDBF2 IDE HNRNPD ADCY9 HNRNPH3 ITPR2 NEFL IGF2BP3 AKAP9 HSPA9 ATPAF1 | 9.75e-06 | 1496 | 128 | 18 | 32877691 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KRT5 ZNF326 MYL6 RCN2 TFIP11 DBN1 ARHGAP35 PRPF40A HNRNPD AKAP8L HNRNPH3 NEFL IGF2BP3 USP7 CPSF3 | 1.12e-05 | 1082 | 128 | 15 | 38697112 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | ZNF326 MYL6 MYO1E SMC4 DBN1 PRPF40A ARPC4 HNRNPD MPRIP IGF2BP3 USP7 UTP20 CPSF3 HSPA9 | 1.13e-05 | 949 | 128 | 14 | 36574265 |
| Pubmed | 1.16e-05 | 286 | 128 | 8 | 32041737 | ||
| Pubmed | ZNF326 VSNL1 MYL6 MYO1E PEG3 RCN2 TFIP11 PRPF40A AKAP8L MPRIP ANKRD36B IGF2BP3 AKAP9 UBAP2L NMT1 HSPA9 RSBN1L | 1.20e-05 | 1371 | 128 | 17 | 36244648 | |
| Pubmed | 1.25e-05 | 289 | 128 | 8 | 37132043 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.25e-05 | 289 | 128 | 8 | 23752268 | |
| Pubmed | Important amino acid residues that confer CYP2C19 selective activity to CYP2C9. | 1.34e-05 | 2 | 128 | 2 | 18511451 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 25637608 | ||
| Pubmed | Developmental expression of human hepatic CYP2C9 and CYP2C19. | 1.34e-05 | 2 | 128 | 2 | 14634042 | |
| Pubmed | CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract. | 1.34e-05 | 2 | 128 | 2 | 10908295 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 1847130 | ||
| Pubmed | Cytochromes P450 catalyze oxidation of alpha,beta-unsaturated aldehydes. | 1.34e-05 | 2 | 128 | 2 | 17599801 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15385837 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 25518510 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15842554 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 19136640 | ||
| Pubmed | Mouse Cyp2c expression and zonation structure in the liver begins in the early neonatal stage. | 1.34e-05 | 2 | 128 | 2 | 35748067 | |
| Pubmed | Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development. | 1.34e-05 | 2 | 128 | 2 | 32587777 | |
| Pubmed | Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population. | 1.34e-05 | 2 | 128 | 2 | 17201743 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 32683556 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15855721 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 19847408 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17504998 | ||
| Pubmed | Cytochrome P450 2C epoxygenases mediate photochemical stress-induced death of photoreceptors. | 1.34e-05 | 2 | 128 | 2 | 24519941 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 14623888 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22589111 | ||
| Pubmed | CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population. | 1.34e-05 | 2 | 128 | 2 | 15660966 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 18154472 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 27353638 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17298483 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 33115391 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17562299 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 36960518 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 26690534 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 19199010 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 19358898 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 34438105 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 18950703 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 2895926 | ||
| Interaction | CIT interactions | ZNF326 MYL6 MYO1E CENPF RCN2 SMC4 PSMC5 TFIP11 DBN1 RRM1 PRPF40A HNRNPD AKAP8L HNRNPH3 MPRIP NEFL IGF2BP3 AKAP9 MTA3 BRCA1 UBAP2L UTP20 DLG4 HSP90AB2P RSBN1L GOLGA4 NLRP5 | 1.44e-07 | 1450 | 123 | 27 | int:CIT |
| Interaction | PPP1R18 interactions | 2.08e-07 | 141 | 123 | 9 | int:PPP1R18 | |
| Interaction | BAP1 interactions | KRT5 MYL6 ANK3 PSMA5 RCN2 SMC4 PSMC5 DBN1 SHTN1 PIP5K1C PRPF40A HNRNPD AKAP8L AKAP12 NEFL IGF2BP3 FAT1 BRCA1 UBAP2L DIAPH1 USP7 OGA NMT1 HSPA9 GOLGA4 | 3.07e-07 | 1314 | 123 | 25 | int:BAP1 |
| Interaction | KCNA3 interactions | ANK3 CCDC73 ICE2 RCN2 SMC4 PSMC5 PTPN23 RRM1 SHTN1 PRPF40A HNRNPD ADCY9 AKAP12 MPRIP UBAP2L PHACTR4 DLG4 HSPA9 GOLGA4 NLRP5 | 3.11e-07 | 871 | 123 | 20 | int:KCNA3 |
| Interaction | CEP57L1 interactions | 1.88e-06 | 95 | 123 | 7 | int:CEP57L1 | |
| Interaction | NAA40 interactions | MYL6 PSMC5 PTPN23 TFIP11 DBN1 ARHGAP35 SHTN1 PRPF40A AKAP12 MPRIP IGF2BP3 UBAP2L USP7 CGNL1 OGA NMT1 CPSF3 HSPA9 RSBN1L KNL1 | 1.89e-06 | 978 | 123 | 20 | int:NAA40 |
| Interaction | AARD interactions | 2.96e-06 | 17 | 123 | 4 | int:AARD | |
| Interaction | IQGAP1 interactions | AKAP5 MYL6 MYO1E PSMA5 PSMC5 TFIP11 DBN1 PIP5K1C ARPC4 MPRIP UBE2H BRCA1 DIAPH1 USP7 GOLGA4 | 3.23e-06 | 591 | 123 | 15 | int:IQGAP1 |
| Interaction | CTTN interactions | MYO1E IDE DBN1 ARHGAP35 RRM1 PRPF40A ARPC4 MPRIP AKAP9 UBE2H USP7 RPA4 HSPA9 | 3.82e-06 | 450 | 123 | 13 | int:CTTN |
| Interaction | TRIM31 interactions | KRT5 ZNF326 MYL6 RCN2 PRPF40A HNRNPD AKAP8L HNRNPH3 IGF2BP3 UBAP2L USP7 HSP90AB2P HSPA9 | 4.20e-06 | 454 | 123 | 13 | int:TRIM31 |
| Interaction | PPP1CB interactions | GRIPAP1 ZNF326 MYO1E DBN1 ARPC4 HNRNPD HNRNPH3 MPRIP NUAK2 UBE2H BRCA1 DLG4 HSPA9 | 5.97e-06 | 469 | 123 | 13 | int:PPP1CB |
| Interaction | RNF6 interactions | 7.05e-06 | 76 | 123 | 6 | int:RNF6 | |
| Interaction | FZR1 interactions | KRT5 CDR2 MYL6 DTYMK PSMA5 RCN2 SMC4 PSMC5 KAT2A ARHGAP35 RRM1 HNRNPD AKAP8L HNRNPH3 IGF2BP3 MTA3 UBAP2L USP7 DLG4 CPSF3 HSPA9 | 7.98e-06 | 1172 | 123 | 21 | int:FZR1 |
| Interaction | PPP1CC interactions | ZNF326 MYL6 MYO1E ZDBF2 DBN1 RRM1 PRPF40A HNRNPH3 MPRIP NEFL IGF2BP3 UBE2H BRCA1 PHACTR4 USP7 KNL1 | 1.09e-05 | 738 | 123 | 16 | int:PPP1CC |
| Interaction | CCDC146 interactions | 1.10e-05 | 82 | 123 | 6 | int:CCDC146 | |
| Interaction | VASP interactions | PITRM1 IFT74 PSMA5 PTPN23 DBN1 ARHGAP35 PRPF40A FAT1 PHACTR4 DIAPH1 | 1.32e-05 | 294 | 123 | 10 | int:VASP |
| Interaction | BIRC3 interactions | ZNF326 MYL6 PITRM1 DNAH10 MAT2B CENPF PSMA5 RCN2 SMC4 PSMC5 IDE DBN1 PRPF40A HNRNPD HNRNPH3 UBAP2L DIAPH1 USP7 UTP20 CPSF3 HSPA9 GOLGA4 | 1.73e-05 | 1334 | 123 | 22 | int:BIRC3 |
| Interaction | EED interactions | ZNF326 MYL6 MYO1E VPS13C DTYMK PSMA5 PEG3 SMC4 TFIP11 DBN1 RRM1 PRPF40A ARPC4 HNRNPD HNRNPH3 MPRIP MTA3 BRCA1 USP7 UTP20 CGNL1 CPSF3 HSPA9 | 1.91e-05 | 1445 | 123 | 23 | int:EED |
| Interaction | CAPZB interactions | MYL6 PSMA5 SH3BP1 IDE DBN1 SHTN1 HNRNPD AKAP8L MPRIP ITPR2 IGF2BP3 GPBP1L1 UBE2H BRCA1 UBAP2L USP7 HSP90AB2P OGA HSPA9 | 1.97e-05 | 1049 | 123 | 19 | int:CAPZB |
| Interaction | PSMD14 interactions | DNAH10 CENPE ICE2 RGS22 PSMA5 PSMC5 NEFL NRBP2 UBE2H BRCA1 HSPA9 RSBN1L KNL1 | 2.06e-05 | 527 | 123 | 13 | int:PSMD14 |
| Interaction | ACTC1 interactions | PHACTR2 MYL6 CENPF PSMC5 TFIP11 DBN1 ARHGAP35 SHTN1 PRPF40A ARPC4 HNRNPD MPRIP PHACTR4 DIAPH1 USP7 | 2.18e-05 | 694 | 123 | 15 | int:ACTC1 |
| Interaction | PPP1CA interactions | ZNF326 CENPE MAT2B DBN1 HNRNPD AKAP9 UBE2H BRCA1 PHACTR4 DIAPH1 DLG4 RPA4 HSPA9 KNL1 PHACTR1 | 2.26e-05 | 696 | 123 | 15 | int:PPP1CA |
| Interaction | AURKA interactions | ZNF326 PITRM1 CENPE PSMA5 RCN2 PTPN23 DBN1 HNRNPD AKAP8L IGF2BP3 MTA3 BRCA1 USP7 CPSF3 HSPA9 | 2.26e-05 | 696 | 123 | 15 | int:AURKA |
| Interaction | TRIM14 interactions | TSGA10 SMC4 DBN1 SHTN1 HNRNPD AKAP8L HNRNPH3 AKAP12 IGF2BP3 FAT1 OGA | 2.33e-05 | 383 | 123 | 11 | int:TRIM14 |
| Interaction | PRC1 interactions | ZNF326 MYL6 MYO1E CENPE CENPF SMC4 TFIP11 DBN1 PRPF40A HNRNPD HNRNPH3 ITPR2 NEFL IGF2BP3 AKAP9 BRCA1 UTP20 RPA4 | 2.52e-05 | 973 | 123 | 18 | int:PRC1 |
| Interaction | ECT2 interactions | MYL6 MYO1E VPS13C PABPC4L DBN1 ARHGAP35 ARPC4 HNRNPD AKAP8L MPRIP ITPR2 NEFL IGF2BP3 USP7 UTP20 HSP90AB2P NLRP5 | 2.78e-05 | 887 | 123 | 17 | int:ECT2 |
| Interaction | EZR interactions | ANK3 IFT74 ZSWIM2 DBN1 ARHGAP35 HNRNPD AKAP12 MPRIP UBE2H BRCA1 PHACTR4 OGA NMT1 | 3.39e-05 | 553 | 123 | 13 | int:EZR |
| Interaction | HNRNPM interactions | ZNF326 PSMA5 TSGA10 SMC4 TFIP11 PRPF40A HNRNPD IGF2BP3 AKAP9 UBE2H BRCA1 USP7 NMT1 RPA4 HSPA9 | 3.50e-05 | 723 | 123 | 15 | int:HNRNPM |
| Interaction | STIP1 interactions | ZNF326 RCN2 SMC4 PSMC5 PTPN23 RRM1 HNRNPD HNRNPH3 NRBP2 UBE2H BRCA1 DIAPH1 USP7 HSP90AB2P CPSF3 RPA4 HSPA9 NLRP5 | 3.91e-05 | 1006 | 123 | 18 | int:STIP1 |
| Interaction | SH3BGRL interactions | 4.13e-05 | 152 | 123 | 7 | int:SH3BGRL | |
| Interaction | FAM161A interactions | 4.88e-05 | 156 | 123 | 7 | int:FAM161A | |
| Interaction | GSPT2 interactions | 5.00e-05 | 107 | 123 | 6 | int:GSPT2 | |
| Interaction | BMI1 interactions | ZNF326 PABPC4L TFIP11 DBN1 RRM1 HNRNPD AKAP8L ITPR2 IGF2BP3 AKAP9 UBAP2L USP7 UTP20 CGNL1 | 5.03e-05 | 659 | 123 | 14 | int:BMI1 |
| Interaction | RHOB interactions | PHACTR2 AKAP5 MYL6 ANK3 MYO1E ARHGAP35 ADCY9 AKAP12 MPRIP ANKRD13A FAT1 STX3 PHACTR4 DIAPH1 UTP20 HSPA9 | 5.26e-05 | 840 | 123 | 16 | int:RHOB |
| Interaction | AMPD2 interactions | 5.27e-05 | 108 | 123 | 6 | int:AMPD2 | |
| Interaction | DHX9 interactions | ZNF326 PSMA5 PRPF40A HNRNPD AKAP8L HNRNPH3 IGF2BP3 AKAP9 UBE2H BRCA1 USP7 OGA NMT1 RPA4 | 5.29e-05 | 662 | 123 | 14 | int:DHX9 |
| Interaction | KRT6A interactions | 5.73e-05 | 160 | 123 | 7 | int:KRT6A | |
| Interaction | PSMC3 interactions | ZNF326 CYP2C9 PSMA5 SMC4 PSMC5 MPRIP ITPR2 UBE2H BRCA1 DIAPH1 GOLGA4 | 5.98e-05 | 425 | 123 | 11 | int:PSMC3 |
| Interaction | CFAP184 interactions | 6.20e-05 | 162 | 123 | 7 | int:CFAP184 | |
| Interaction | DISC1 interactions | GRIPAP1 MYL6 IFT74 TSGA10 TFIP11 DBN1 CCDC141 ARPC4 AKAP9 UBAP2L USP7 | 6.51e-05 | 429 | 123 | 11 | int:DISC1 |
| Interaction | KIF20A interactions | MYL6 MYO1E CENPE PSMA5 PTPN23 TFIP11 DBN1 PRPF40A ARPC4 HNRNPD AKAP8L HNRNPH3 MPRIP ITPR2 NEFL IGF2BP3 BRCA1 UBAP2L | 6.96e-05 | 1052 | 123 | 18 | int:KIF20A |
| Interaction | FGF11 interactions | 8.39e-05 | 170 | 123 | 7 | int:FGF11 | |
| Interaction | CDK2 interactions | MYL6 PSMA5 SMC4 PSMC5 KAT2A DBN1 RRM1 DHRS1 HNRNPD MPRIP IGF2BP3 UBE2H BRCA1 USP7 HSPA9 | 8.60e-05 | 783 | 123 | 15 | int:CDK2 |
| Interaction | TRIR interactions | 8.98e-05 | 74 | 123 | 5 | int:TRIR | |
| Interaction | PRPF18 interactions | 9.47e-05 | 120 | 123 | 6 | int:PRPF18 | |
| Interaction | C2CD6 interactions | 9.57e-05 | 75 | 123 | 5 | int:C2CD6 | |
| Interaction | CCDC187 interactions | 1.02e-04 | 76 | 123 | 5 | int:CCDC187 | |
| Interaction | DIAPH1 interactions | 1.04e-04 | 176 | 123 | 7 | int:DIAPH1 | |
| Interaction | USP11 interactions | DONSON MYL6 CENPE PTPN23 DBN1 HNRNPD MPRIP IGF2BP3 BRCA1 USP7 HSP90AB2P HSPA9 | 1.15e-04 | 539 | 123 | 12 | int:USP11 |
| Interaction | DTNA interactions | 1.19e-04 | 125 | 123 | 6 | int:DTNA | |
| Interaction | FUBP1 interactions | ZNF326 TFIP11 PRPF40A ARPC4 HNRNPD HNRNPH3 IGF2BP3 BRCA1 CPSF3 | 1.19e-04 | 309 | 123 | 9 | int:FUBP1 |
| Interaction | SYCE1 interactions | 1.29e-04 | 127 | 123 | 6 | int:SYCE1 | |
| Interaction | SNRNP40 interactions | ZNF326 MYL6 MYO1E TFIP11 ZDBF2 PRPF40A HNRNPD HNRNPH3 GPBP1L1 UBE2H BRCA1 RSBN1L KNL1 | 1.41e-04 | 637 | 123 | 13 | int:SNRNP40 |
| Interaction | PEG3 interactions | 1.42e-04 | 17 | 123 | 3 | int:PEG3 | |
| Interaction | DYRK1A interactions | MYO1E CENPF ICE2 RCN2 DBN1 RRM1 MPRIP IGF2BP3 MTA3 BRCA1 USP7 RSBN1L | 1.44e-04 | 552 | 123 | 12 | int:DYRK1A |
| Interaction | CBX8 interactions | 1.47e-04 | 249 | 123 | 8 | int:CBX8 | |
| Interaction | GLDC interactions | DBN1 PRPF40A HNRNPD HNRNPH3 MPRIP IGF2BP3 UBAP2L CPSF3 HSPA9 | 1.58e-04 | 321 | 123 | 9 | int:GLDC |
| Interaction | PRMT1 interactions | ZNF326 SMC4 PSMC5 DBN1 HNRNPD AKAP8L HNRNPH3 NEFL IGF2BP3 NRBP2 UBE2H BRCA1 UBAP2L USP7 HSPA9 GOLGA4 | 1.69e-04 | 929 | 123 | 16 | int:PRMT1 |
| Interaction | EFTUD2 interactions | KRT5 MYL6 MYO1E MAT2B PSMA5 SMC4 TFIP11 ARHGAP35 RRM1 ARPC4 HNRNPD IGF2BP3 UBE2H BRCA1 UBAP2L DIAPH1 USP7 HSP90AB2P NMT1 HSPA9 GOLGA4 | 1.75e-04 | 1449 | 123 | 21 | int:EFTUD2 |
| Interaction | CGNL1 interactions | 1.77e-04 | 46 | 123 | 4 | int:CGNL1 | |
| Interaction | FBXO42 interactions | 1.93e-04 | 259 | 123 | 8 | int:FBXO42 | |
| Interaction | STMN1 interactions | 1.97e-04 | 195 | 123 | 7 | int:STMN1 | |
| Interaction | MYH9 interactions | MYL6 MYO1E TSGA10 SMC4 PSMC5 DBN1 ARPC4 MPRIP ITPR2 UBE2H BRCA1 USP7 HSPA9 GOLGA4 | 2.07e-04 | 754 | 123 | 14 | int:MYH9 |
| Interaction | OGFR interactions | 2.09e-04 | 48 | 123 | 4 | int:OGFR | |
| Interaction | TLN1 interactions | 2.19e-04 | 264 | 123 | 8 | int:TLN1 | |
| Interaction | TSGA10IP interactions | 2.20e-04 | 140 | 123 | 6 | int:TSGA10IP | |
| Interaction | CDC5L interactions | DTYMK SMC4 PSMC5 ZDBF2 PRPF40A AKAP9 UBE2H BRCA1 GLE1 DIAPH1 USP7 CPSF3 RPA4 MTUS2 KNL1 | 2.25e-04 | 855 | 123 | 15 | int:CDC5L |
| Interaction | ADRM1 interactions | 2.31e-04 | 266 | 123 | 8 | int:ADRM1 | |
| Interaction | MEPCE interactions | KRT5 MYL6 DTYMK PSMA5 SMC4 PSMC5 DBN1 PRPF40A HNRNPD IGF2BP3 MTA3 UBE2H HSP90AB2P HSPA9 NLRP5 | 2.37e-04 | 859 | 123 | 15 | int:MEPCE |
| Interaction | ZNF490 interactions | 2.45e-04 | 50 | 123 | 4 | int:ZNF490 | |
| Interaction | PSMD7 interactions | 2.55e-04 | 270 | 123 | 8 | int:PSMD7 | |
| Interaction | IMPDH2 interactions | PSMC5 PTPN23 SHTN1 IGF2BP3 AKAP9 UBE2H BRCA1 OGA CPSF3 GOLGA4 | 2.57e-04 | 420 | 123 | 10 | int:IMPDH2 |
| Interaction | CALM3 interactions | 2.59e-04 | 343 | 123 | 9 | int:CALM3 | |
| Interaction | FXR1 interactions | CDR2 GRIPAP1 MYL6 CENPF PSMC5 NEFL AKAP9 UBAP2L GLE1 USP7 RPA4 MTUS2 HSPA9 | 2.63e-04 | 679 | 123 | 13 | int:FXR1 |
| Interaction | RND3 interactions | 2.75e-04 | 273 | 123 | 8 | int:RND3 | |
| Interaction | RBBP7 interactions | CENPE VPS13C PSMA5 SMC4 PRPF40A MTA3 UBE2H BRCA1 RPA4 GOLGA4 KNL1 | 2.80e-04 | 507 | 123 | 11 | int:RBBP7 |
| Interaction | FOXO1 interactions | 2.82e-04 | 347 | 123 | 9 | int:FOXO1 | |
| Interaction | CAP1 interactions | 2.83e-04 | 207 | 123 | 7 | int:CAP1 | |
| Interaction | KIF5B interactions | 2.88e-04 | 348 | 123 | 9 | int:KIF5B | |
| Interaction | FBP1 interactions | 2.88e-04 | 348 | 123 | 9 | int:FBP1 | |
| Interaction | PFN1 interactions | IFT74 VPS13C DBN1 ARHGAP35 SHTN1 MPRIP AKAP9 UBE2H BRCA1 DIAPH1 GOLGA4 | 2.89e-04 | 509 | 123 | 11 | int:PFN1 |
| Interaction | KCTD13 interactions | KRT5 MYL6 ANK3 MYO1E PACSIN1 DBN1 ARHGAP35 PRPF40A ARPC4 HNRNPD MPRIP ITPR2 NUAK2 NEFL UBAP2L USP7 DLG4 CGNL1 MTUS2 HSPA9 | 2.91e-04 | 1394 | 123 | 20 | int:KCTD13 |
| Interaction | TTC23 interactions | 2.91e-04 | 208 | 123 | 7 | int:TTC23 | |
| Interaction | FAM120A interactions | ZNF326 PABPC4L TFIP11 HNRNPD IGF2BP3 UBE2H BRCA1 UBAP2L RPA4 | 2.94e-04 | 349 | 123 | 9 | int:FAM120A |
| Interaction | CAPZA2 interactions | 3.09e-04 | 430 | 123 | 10 | int:CAPZA2 | |
| Interaction | CCDC68 interactions | 3.14e-04 | 22 | 123 | 3 | int:CCDC68 | |
| Interaction | SNRNP70 interactions | ZNF326 MYL6 TFIP11 DBN1 ARHGAP35 PRPF40A HNRNPD AKAP8L HNRNPH3 MPRIP IGF2BP3 NRBP2 UBE2H USP7 CPSF3 RSBN1L | 3.23e-04 | 984 | 123 | 16 | int:SNRNP70 |
| Interaction | DCTN2 interactions | 3.40e-04 | 356 | 123 | 9 | int:DCTN2 | |
| Interaction | GAS2L2 interactions | 3.54e-04 | 55 | 123 | 4 | int:GAS2L2 | |
| Interaction | CAPN1 interactions | 3.56e-04 | 215 | 123 | 7 | int:CAPN1 | |
| Interaction | TRPA1 interactions | 3.65e-04 | 5 | 123 | 2 | int:TRPA1 | |
| Interaction | CYP2C19 interactions | 3.65e-04 | 5 | 123 | 2 | int:CYP2C19 | |
| Interaction | HDAC11 interactions | 3.68e-04 | 154 | 123 | 6 | int:HDAC11 | |
| Interaction | ZCCHC8 interactions | 3.68e-04 | 154 | 123 | 6 | int:ZCCHC8 | |
| Interaction | BTF3 interactions | KRT5 MYL6 ANK3 MYO1E RCN2 DBN1 ARPC4 MPRIP ITPR2 IGF2BP3 MTA3 UBE2H UBAP2L HSPA9 | 3.73e-04 | 799 | 123 | 14 | int:BTF3 |
| Interaction | PSMA3 interactions | DONSON PSMA5 PSMC5 PTPN23 HNRNPH3 UBE2H USP7 RPA4 HSPA9 GOLGA4 | 3.91e-04 | 443 | 123 | 10 | int:PSMA3 |
| Interaction | PBK interactions | 3.94e-04 | 156 | 123 | 6 | int:PBK | |
| Interaction | OBSL1 interactions | KRT5 ZNF326 CENPF TSGA10 PRPF40A HNRNPD HNRNPH3 NEFL SLC9C1 IGF2BP3 UBE2H UBAP2L UTP20 HSPA9 RSBN1L | 3.97e-04 | 902 | 123 | 15 | int:OBSL1 |
| Interaction | RNF38 interactions | 4.05e-04 | 102 | 123 | 5 | int:RNF38 | |
| Interaction | GRB2 interactions | KRT5 PSMA5 SH3BP1 PTPN23 DBN1 ARHGAP35 HNRNPD AKAP12 ANKRD13A MTA3 UBE2H PHACTR4 DIAPH1 HSPA9 | 4.07e-04 | 806 | 123 | 14 | int:GRB2 |
| GeneFamily | Phosphatase and actin regulators | 3.86e-07 | 4 | 84 | 3 | 679 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.97e-04 | 181 | 84 | 6 | 694 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 3.24e-04 | 29 | 84 | 3 | 396 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 9.37e-04 | 10 | 84 | 2 | 53 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.11e-03 | 18 | 84 | 2 | 91 | |
| GeneFamily | RNA binding motif containing | 3.15e-03 | 213 | 84 | 5 | 725 | |
| GeneFamily | Regulators of G-protein signaling | 4.23e-03 | 21 | 84 | 2 | 720 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 5.33e-03 | 76 | 84 | 3 | 743 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS | 1.98e-06 | 79 | 123 | 6 | M40003 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 2.23e-06 | 180 | 123 | 8 | M2961 | |
| Coexpression | GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP | 3.88e-06 | 194 | 123 | 8 | M3540 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | CDR2 ZNF326 CENPE CENPF PACSIN1 ICE2 DTYMK SMC4 PRPF40A ADCY9 ANKRD36B NEFL BLOC1S6 BRCA1 CPSF3 ATPAF1 KNL1 | 6.03e-06 | 1023 | 123 | 17 | M17122 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | DONSON CENPF DTYMK PSMA5 SMC4 IDE RRM1 PRPF40A IGF2BP3 BRCA1 CPSF3 HSPA9 KNL1 | 1.09e-05 | 644 | 123 | 13 | M10501 |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 1.28e-05 | 164 | 123 | 7 | M19957 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 2.02e-05 | 176 | 123 | 7 | M2981 | |
| Coexpression | BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP | 2.15e-05 | 12 | 123 | 3 | M34000 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 2.97e-05 | 187 | 123 | 7 | M2984 | |
| Coexpression | GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_DN | 4.56e-05 | 200 | 123 | 7 | M5996 | |
| Coexpression | SASSON_RESPONSE_TO_FORSKOLIN_DN | 5.10e-05 | 85 | 123 | 5 | M12924 | |
| Coexpression | SASSON_RESPONSE_TO_GONADOTROPHINS_DN | 5.39e-05 | 86 | 123 | 5 | M17143 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP | 6.45e-05 | 145 | 123 | 6 | M3045 | |
| Coexpression | KAUFFMANN_DNA_REPLICATION_GENES | 6.70e-05 | 146 | 123 | 6 | M9372 | |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_24HR_UP | PHACTR2 MYL6 CENPF RCN2 SMC4 RRM1 SHTN1 CREG1 HNRNPH3 UBAP2L USP7 | 6.95e-05 | 561 | 123 | 11 | M1463 |
| Coexpression | BIDUS_METASTASIS_UP | 8.55e-05 | 221 | 123 | 7 | M15866 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 8.85e-05 | 300 | 123 | 8 | M39059 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 1.21e-04 | 402 | 123 | 9 | MM454 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 1.52e-04 | 107 | 123 | 5 | MM947 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 1.66e-04 | 109 | 123 | 5 | M2451 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN | 1.76e-04 | 174 | 123 | 6 | M2996 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CENPE CENPF ARHGAP35 ADCY9 HNRNPH3 IGF2BP3 FAT1 AKAP9 BRCA1 FARS2 USP7 UTP20 GOLGA4 | 1.97e-04 | 856 | 123 | 13 | M4500 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 2.08e-04 | 432 | 123 | 9 | M41149 | |
| Coexpression | GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP | 2.24e-04 | 182 | 123 | 6 | M8126 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN | 2.36e-04 | 64 | 123 | 4 | MM1257 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | CENPE CENPF DTYMK PSMA5 RCN2 SMC4 RRM1 BRCA1 UBAP2L UTP20 NMT1 HSPA9 | 2.50e-04 | 761 | 123 | 12 | M11961 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CENPE IFT74 VPS13C ICE2 RCN2 SMC4 SHTN1 ITPR2 BRCA1 GOLGA4 KNL1 | 2.71e-04 | 656 | 123 | 11 | M18979 |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 2.72e-04 | 27 | 123 | 3 | M2483 | |
| Coexpression | MISSIAGLIA_REGULATED_BY_METHYLATION_DN | 2.81e-04 | 122 | 123 | 5 | M6866 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 3.03e-04 | 28 | 123 | 3 | MM1323 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | DONSON CENPE CENPF ICE2 DTYMK RCN2 SMC4 PABPC4L ZDBF2 RRM1 PRPF40A HNRNPD BRCA1 UBAP2L ANKIB1 CPSF3 KNL1 | 3.12e-04 | 1407 | 123 | 17 | M14427 |
| Coexpression | WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN | 3.24e-04 | 6 | 123 | 2 | MM971 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 3.24e-04 | 195 | 123 | 6 | M13736 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP | 3.33e-04 | 196 | 123 | 6 | M8503 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP | 3.38e-04 | 127 | 123 | 5 | M40905 | |
| Coexpression | GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN | 3.52e-04 | 198 | 123 | 6 | M5084 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | CDR2 DONSON MAT2B CENPF DTYMK SMC4 RRM1 CBR3 PRPF40A HNRNPD AKAP12 BRCA1 GLE1 NMT1 HSPA9 KNL1 | 3.57e-04 | 1290 | 123 | 16 | M80 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | CDR2 SMC4 TFIP11 ZDBF2 HNRNPD HNRNPH3 UBAP2L OGA HSPA9 GOLGA4 PHACTR1 | 3.68e-04 | 680 | 123 | 11 | M41089 |
| Coexpression | GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN | 3.71e-04 | 200 | 123 | 6 | M317 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 3.71e-04 | 200 | 123 | 6 | M3446 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN | 3.71e-04 | 200 | 123 | 6 | M3742 | |
| Coexpression | GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN | 3.71e-04 | 200 | 123 | 6 | M9755 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 3.71e-04 | 200 | 123 | 6 | M7457 | |
| Coexpression | GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP | 3.71e-04 | 200 | 123 | 6 | M7335 | |
| Coexpression | GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN | 3.71e-04 | 200 | 123 | 6 | M8691 | |
| Coexpression | GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | 3.71e-04 | 200 | 123 | 6 | M6252 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 3.71e-04 | 200 | 123 | 6 | M5901 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_UP | 3.71e-04 | 200 | 123 | 6 | M9123 | |
| Coexpression | GSE40273_EOS_KO_VS_WT_TREG_DN | 3.71e-04 | 200 | 123 | 6 | M9130 | |
| Coexpression | GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP | 3.71e-04 | 200 | 123 | 6 | M3041 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CDR2 ZNF326 CENPE CENPF ICE2 SMC4 ARHGAP35 PRPF40A AKAP8L HNRNPH3 SYCE2 AKAP9 UBAP2L PXYLP1 OGA USP27X KNL1 | 1.53e-07 | 629 | 124 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | FAM184A CENPE CENPF IFT74 ICE2 TSGA10 SMC4 ZDBF2 HNRNPH3 NUAK2 NEFL IGF2BP3 SCUBE1 AKAP9 BRCA1 ANKIB1 UTP20 PXYLP1 NMT1 GOLGA4 KNL1 | 2.70e-07 | 989 | 124 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | FAM184A ZNF326 DONSON CENPE CENPF IFT74 ICE2 TSGA10 SMC4 ZDBF2 RRM1 PRPF40A HNRNPD SYCE2 NUAK2 IGF2BP3 AKAP9 BRCA1 USP7 UTP20 NMT1 USP27X KNL1 | 9.22e-07 | 1257 | 124 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.94e-06 | 192 | 124 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | FAM184A CENPE CENPF IFT74 ICE2 SMC4 AKAP9 BRCA1 ANKIB1 GOLGA4 KNL1 | 2.17e-06 | 311 | 124 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | FAM184A ZNF326 DONSON CENPE CENPF IFT74 ICE2 TSGA10 SMC4 ZDBF2 RRM1 PRPF40A HNRNPD SYCE2 NUAK2 IGF2BP3 SCUBE1 AKAP9 BRCA1 USP7 UTP20 NMT1 USP27X KNL1 | 3.34e-06 | 1459 | 124 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | PEG3 SMC4 KAT2A DBN1 RRM1 ARPC4 NEFL BLOC1S6 IGF2BP3 UBAP2L GLE1 HSPA9 | 9.44e-06 | 435 | 124 | 12 | gudmap_developingGonad_e11.5_testes and mesonephros_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.74e-05 | 192 | 124 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | ZNF326 DNAH10 CENPE CENPF ICE2 SMC4 ABCC9 SAMSN1 CREG1 PRPF40A AKAP8L SYCE2 AKAP9 GLE1 DIAPH1 OGA USP27X KNL1 | 1.76e-05 | 989 | 124 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | VSNL1 AKAP5 DRP2 VPS13C ICE2 RGS22 PEG3 SHTN1 CREG1 CBR3 AKAP8L ITPR2 SCUBE1 AKAP9 MTA3 UBE2H | 1.84e-05 | 804 | 124 | 16 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | DNAH10 CENPE CENPF SMC4 ZDBF2 SHTN1 NUAK2 SCUBE1 AKAP9 BRCA1 UTP20 NMT1 | 3.25e-05 | 493 | 124 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | PEG3 SMC4 PSMC5 KAT2A DBN1 RRM1 PRPF40A ARPC4 HNRNPD NEFL BLOC1S6 IGF2BP3 BRCA1 UBAP2L GLE1 HSPA9 | 3.26e-05 | 843 | 124 | 16 | gudmap_developingGonad_e11.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | PEG3 PSMC5 KAT2A DBN1 RRM1 ARPC4 HNRNPD BLOC1S6 IGF2BP3 BRCA1 UBAP2L HSPA9 | 3.58e-05 | 498 | 124 | 12 | gudmap_developingGonad_e11.5_testes_k5_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | CENPE CENPF TSGA10 SMC4 ZDBF2 NUAK2 NEFL AKAP9 BRCA1 NMT1 GOLGA4 KNL1 | 3.58e-05 | 498 | 124 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.93e-05 | 349 | 124 | 10 | gudmap_developingGonad_P2_testes_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | FAM184A ZNF326 CENPE CENPF IFT74 ICE2 TSGA10 SMC4 ZDBF2 PRPF40A NEFL NRBP2 AKAP9 BRCA1 DLG4 PXYLP1 KNL1 PHACTR1 | 4.38e-05 | 1060 | 124 | 18 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500 | PEG3 SMC4 KAT2A DBN1 RRM1 NEFL BLOC1S6 IGF2BP3 UBAP2L GLE1 HSPA9 | 5.20e-05 | 437 | 124 | 11 | gudmap_developingGonad_e11.5_testes_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_1000 | RGS5 PEG3 KAT2A DBN1 PRPF40A ARPC4 IGF2BP3 UBAP2L GLE1 HSPA9 | 5.34e-05 | 362 | 124 | 10 | gudmap_developingGonad_e18.5_testes_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | FAM184A ZNF326 DRP2 CENPE CENPF TSGA10 SLC5A7 SMC4 ABCC9 ZDBF2 SHTN1 NUAK2 SCUBE1 STX3 AKAP9 BRCA1 NMT1 | 6.05e-05 | 986 | 124 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 6.48e-05 | 231 | 124 | 8 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | RGS5 PEG3 PSMC5 KAT2A DBN1 RRM1 ARPC4 BLOC1S6 IGF2BP3 BRCA1 UBAP2L HSPA9 | 6.88e-05 | 533 | 124 | 12 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | RBM44 PEG3 SMC4 KAT2A DBN1 RRM1 PRPF40A ARPC4 ADCY7 NUAK2 NRBP2 BRCA1 UBAP2L GLE1 HSPA9 | 8.74e-05 | 819 | 124 | 15 | gudmap_developingGonad_P2_testes_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | VSNL1 AKAP5 DRP2 RGS5 PEG3 PABPC4L CCDC141 CBR3 ITPR2 SCUBE1 | 9.50e-05 | 388 | 124 | 10 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | 1.17e-04 | 398 | 124 | 10 | GSM538338_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | RGS5 PEG3 SMC4 PSMC5 KAT2A DBN1 RRM1 ARPC4 NEFL BLOC1S6 IGF2BP3 BRCA1 UBAP2L GLE1 HSPA9 | 1.22e-04 | 844 | 124 | 15 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | FAM184A ZNF326 FMO1 DONSON CENPE CENPF IFT74 PEG3 TSGA10 SMC4 ZDBF2 SAMSN1 HNRNPD NUAK2 NEFL FAT1 SCUBE1 AKAP9 BRCA1 KNL1 | 1.30e-04 | 1370 | 124 | 20 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | FAM184A ZNF326 DONSON PITRM1 CENPE MAT2B CENPF IFT74 SMC4 ZDBF2 IDE KAT2A PRPF40A AKAP12 NEFL IGF2BP3 AKAP9 BRCA1 UTP20 KNL1 | 1.31e-04 | 1371 | 124 | 20 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500 | 1.38e-04 | 406 | 124 | 10 | gudmap_developingGonad_e12.5_testes_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | VSNL1 AKAP5 DRP2 CENPE CENPF RGS5 PEG3 ABCC9 PABPC4L CCDC141 SYCE2 SCUBE1 DLG4 KNL1 | 1.80e-04 | 777 | 124 | 14 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | DNAH10 CENPE CENPF RGS5 VPS13C SMC4 ZDBF2 SHTN1 PRPF40A NUAK2 SCUBE1 AKAP9 BRCA1 UTP20 NMT1 PHACTR1 | 1.96e-04 | 983 | 124 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | FAM184A ZNF326 CENPE CENPF IFT74 ICE2 TSGA10 SMC4 ZDBF2 PRPF40A NUAK2 NEFL SCUBE1 NRBP2 AKAP9 BRCA1 DLG4 PXYLP1 KNL1 PHACTR1 | 1.98e-04 | 1414 | 124 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 2.19e-04 | 146 | 124 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | DONSON CENPE CENPF VPS13C SMC4 PSMC5 ZDBF2 PRPF40A BRCA1 USP7 NMT1 | 2.91e-04 | 532 | 124 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | RBM44 PEG3 SMC4 PABPC4L KAT2A DBN1 RRM1 PRPF40A ARPC4 IGF2BP3 BRCA1 UBAP2L GLE1 HSPA9 | 3.09e-04 | 819 | 124 | 14 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.15e-04 | 291 | 124 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#3_top-relative-expression-ranked_100 | 3.34e-04 | 5 | 124 | 2 | gudmap_kidney_adult_RenCorpuscGlomer_k3_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | FAM184A CENPE CENPF IFT74 SMC4 ZDBF2 HNRNPH3 AKAP9 BRCA1 ANKIB1 PXYLP1 NMT1 GOLGA4 KNL1 | 3.57e-04 | 831 | 124 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 4.33e-04 | 232 | 124 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.35e-04 | 166 | 124 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 4.38e-04 | 385 | 124 | 9 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#3_top-relative-expression-ranked_500 | 5.72e-04 | 28 | 124 | 3 | gudmap_developingGonad_e12.5_testes_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | 6.30e-04 | 492 | 124 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | FAM184A CENPE TSGA10 SMC4 ZDBF2 SHTN1 NUAK2 SCUBE1 STX3 AKAP9 | 6.70e-04 | 496 | 124 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | 7.36e-04 | 414 | 124 | 9 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ZNF326 MYO1E ZDBF2 ARHGAP35 HNRNPH3 MPRIP SYCE2 PXYLP1 OGA USP27X GOLGA4 | 7.40e-04 | 595 | 124 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.75e-04 | 31 | 124 | 3 | gudmap_developingGonad_e14.5_ testes_1000_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | VSNL1 AKAP5 DRP2 RGS5 PEG3 ABCC9 SHTN1 CCDC141 CBR3 SYCE2 ITPR2 SCUBE1 DLG4 | 7.89e-04 | 797 | 124 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 7.92e-04 | 186 | 124 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.96e-04 | 71 | 124 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | ZNF326 DONSON PITRM1 CENPE CENPF IFT74 ICE2 SMC4 ZDBF2 KAT2A HNRNPD HNRNPH3 NUAK2 NEFL IGF2BP3 SCUBE1 AKAP9 BRCA1 | 8.28e-04 | 1347 | 124 | 18 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | AKAP5 DRP2 ICE2 RGS22 PEG3 SHTN1 CREG1 CBR3 ITPR2 SCUBE1 AKAP9 MTA3 CGNL1 | 8.45e-04 | 803 | 124 | 13 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | RBM44 ZNF326 VSNL1 AKAP5 DRP2 CENPE RGS5 PEG3 SMC4 PABPC4L NEFL UBAP2L USP7 | 8.55e-04 | 804 | 124 | 13 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.60e-04 | 339 | 124 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ZNF326 ANK3 PITRM1 CENPE CENPF IFT74 ICE2 PEG3 SMC4 ZDBF2 PRPF40A ITPR2 AKAP9 BRCA1 USP7 USP27X KNL1 | 8.90e-04 | 1241 | 124 | 17 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_500 | 9.33e-04 | 33 | 124 | 3 | gudmap_developingGonad_P2_ovary_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | RGS5 PEG3 SMC4 KAT2A DBN1 PRPF40A ARPC4 ADCY7 IGF2BP3 NRBP2 UBAP2L GLE1 HSPA9 | 9.57e-04 | 814 | 124 | 13 | gudmap_developingGonad_e18.5_testes_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.78e-04 | 75 | 124 | 4 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.93e-04 | 432 | 124 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.08e-03 | 271 | 124 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.12e-03 | 199 | 124 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_1000 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-10 | 198 | 128 | 10 | 6a10bb81817ab606f1f5a2bd8cfe77ef2fb3f2fb | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.01e-09 | 193 | 128 | 9 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.24e-09 | 194 | 128 | 9 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.24e-09 | 194 | 128 | 9 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.24e-09 | 194 | 128 | 9 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.24e-09 | 194 | 128 | 9 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.24e-09 | 194 | 128 | 9 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.24e-09 | 194 | 128 | 9 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.73e-09 | 196 | 128 | 9 | 34bd155e6d848eb53d613997c0e244535de30ba3 | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.99e-09 | 197 | 128 | 9 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | MNPs-Dividing_Macrophages|MNPs / lung cells shred on cell class, cell subclass, sample id | 6.54e-09 | 199 | 128 | 9 | 5952980d0ece5d73f3e9f340c56a38b34d2f2309 | |
| ToppCell | LAM-Myeloid-pMacrophage|Myeloid / Condition, Lineage and Cell class | 6.83e-09 | 200 | 128 | 9 | 0078d56337d44074326e8ccd1d412d098d86eeab | |
| ToppCell | LAM-Myeloid-pMacrophage|LAM / Condition, Lineage and Cell class | 6.83e-09 | 200 | 128 | 9 | 7e233d037165c9d3607604aaaf0f368e266567d3 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 6.83e-09 | 200 | 128 | 9 | cfec2f712b870797fab3b0770f16feaafd37e8d5 | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.57e-08 | 181 | 128 | 8 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 6.32e-08 | 184 | 128 | 8 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.59e-08 | 185 | 128 | 8 | 57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 8.09e-08 | 190 | 128 | 8 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 8.43e-08 | 191 | 128 | 8 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | control-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.13e-08 | 193 | 128 | 8 | ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.50e-08 | 194 | 128 | 8 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.50e-08 | 194 | 128 | 8 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.89e-08 | 195 | 128 | 8 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.89e-08 | 195 | 128 | 8 | 47a01b8a92eebeb34ac7f70bf1ab4613a326e24f | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.03e-07 | 196 | 128 | 8 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-07 | 196 | 128 | 8 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-07 | 196 | 128 | 8 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.03e-07 | 196 | 128 | 8 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 1.03e-07 | 196 | 128 | 8 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.03e-07 | 196 | 128 | 8 | 3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-07 | 196 | 128 | 8 | 4f649e3bfd21f21682678828673843a7d51c4ff2 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.03e-07 | 196 | 128 | 8 | 799c290fb3dfacb666dd0dc3c43ec8a86b697ec7 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-07 | 196 | 128 | 8 | 0c003a767c3b58605099dab64b9df0d8e5d8bc4b | |
| ToppCell | Control-Myeloid-proliferating_Myeloid_cells|Control / Disease group,lineage and cell class (2021.01.30) | 1.07e-07 | 197 | 128 | 8 | ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.11e-07 | 198 | 128 | 8 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | distal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.11e-07 | 198 | 128 | 8 | df3f5559ecd1f3cd1fd60e39dbad8741309e83a3 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.11e-07 | 198 | 128 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (0)_NK_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.11e-07 | 198 | 128 | 8 | c5336d9b802393d6fd6f8446ea4bb6befeb97bfd | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.11e-07 | 198 | 128 | 8 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | HSPCs|World / Lineage and Cell class | 1.16e-07 | 199 | 128 | 8 | df1ffc416c6946f1ba182f242a50ee41a571d565 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 1.16e-07 | 199 | 128 | 8 | dee1cf8ee850a2bd57349418a9bcc0948fe9ac9e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-07 | 199 | 128 | 8 | 4af38f5e9d2229d64f7ecdf9c00b4d67e5f86a51 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.16e-07 | 199 | 128 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 1.16e-07 | 199 | 128 | 8 | a0c20b97cb38e493b47a06e9501fc165a78c61b2 | |
| ToppCell | COVID-19_Convalescent-T/NK_proliferative|COVID-19_Convalescent / Disease condition and Cell class | 1.16e-07 | 199 | 128 | 8 | c608d953b852b67a4e36bd63d45f0deec3eefbd9 | |
| ToppCell | Dividing_Macrophages|World / lung cells shred on cell class, cell subclass, sample id | 1.16e-07 | 199 | 128 | 8 | 5c755b6876e164dc847ef7c723f850f227cf3a87 | |
| ToppCell | control-T/NK_proliferative|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.20e-07 | 200 | 128 | 8 | 1da366e35a05f73253629663eeea1fed4ebd7b52 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.20e-07 | 200 | 128 | 8 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-07 | 200 | 128 | 8 | 28c702449040ac15fe4e0c6340bb6f137e88539d | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-07 | 200 | 128 | 8 | 5d11a2c0021805e78d97dc1638bf73ca1faede66 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|COVID-19 / Condition, Lineage and Cell class | 1.20e-07 | 200 | 128 | 8 | b239c711cce967826432fdbd5f88eba98a88bb0c | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 1.20e-07 | 200 | 128 | 8 | 4556bb626ca1a00a6db13d2adb35acb8ba848f9c | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.71e-07 | 163 | 128 | 7 | c1a98d6776b685f20dde049715233e5c73ce3244 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.31e-07 | 174 | 128 | 7 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.31e-07 | 174 | 128 | 7 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 7.89e-07 | 176 | 128 | 7 | a40dfd8c4ba16757ff929b2f03a0628acf334de4 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.88e-07 | 182 | 128 | 7 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 1.03e-06 | 183 | 128 | 7 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-06 | 183 | 128 | 7 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.06e-06 | 184 | 128 | 7 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.27e-06 | 189 | 128 | 7 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 1.36e-06 | 191 | 128 | 7 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 1.36e-06 | 191 | 128 | 7 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l12-14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.41e-06 | 192 | 128 | 7 | 52d0aa51e3b6ab3608a5f40bdde9f8134b3afd94 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 192 | 128 | 7 | 03dcd9405d3d76fc7455066ba5d83c09cd17072d | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 192 | 128 | 7 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-06 | 193 | 128 | 7 | 4a3e456f07e521519faeb9153e8d571cb8fbeaf9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-06 | 193 | 128 | 7 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 1.51e-06 | 194 | 128 | 7 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.51e-06 | 194 | 128 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | Control-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type | 1.51e-06 | 194 | 128 | 7 | 844731b7943d1cfca819b7b89e4e62067bfa0230 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-06 | 194 | 128 | 7 | 5810d8e1f6b983bb346fe06dda22b8ba3f2144a6 | |
| ToppCell | Influenza_Severe-T/NK_proliferative|World / Disease group and Cell class | 1.57e-06 | 195 | 128 | 7 | 6f079c2d7d08110a5e1822ea861b8037eb3f62c9 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.57e-06 | 195 | 128 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.57e-06 | 195 | 128 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-06 | 195 | 128 | 7 | 75759fd7f925725f0ecd07214afcca5aa2158f9e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.57e-06 | 195 | 128 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | (4)_B_Hypermutation|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.57e-06 | 195 | 128 | 7 | 54d2acaff6be6b5604591bdbd7d769ac3e74f223 | |
| ToppCell | ILEUM-non-inflamed-(1)_Highly_activated_T_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.62e-06 | 196 | 128 | 7 | 6a415a2574bd84bd825a2bd6c8e3632a433ff7cf | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 196 | 128 | 7 | 9d4f0a95e49bda25864cbe27e4e86096cba5609f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.62e-06 | 196 | 128 | 7 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | severe-T/NK_proliferative|severe / disease stage, cell group and cell class | 1.62e-06 | 196 | 128 | 7 | 89f005216770dbb84378f5d1f20ca11b0ce40faa | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.62e-06 | 196 | 128 | 7 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(I)|lymph-node_spleen / Manually curated celltypes from each tissue | 1.62e-06 | 196 | 128 | 7 | 32d54c0b487f00c4f8bd765462e484da8a6625c9 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.68e-06 | 197 | 128 | 7 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | Healthy_Control-Lymphoid-T-Proliferating_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.68e-06 | 197 | 128 | 7 | 3ce3dcbbe0edeb5a6fb5596dd6c2b4d6c1d5159d | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 1.68e-06 | 197 | 128 | 7 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | severe-T/NK_proliferative|World / disease stage, cell group and cell class | 1.68e-06 | 197 | 128 | 7 | 6b7b068b103fd4f6ceda8e01f4dd39eefc3b3633 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.68e-06 | 197 | 128 | 7 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.68e-06 | 197 | 128 | 7 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.68e-06 | 197 | 128 | 7 | 2a89a724e8c15a5bb167fdad7eed31444d8c3d68 | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 1.68e-06 | 197 | 128 | 7 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.68e-06 | 197 | 128 | 7 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.68e-06 | 197 | 128 | 7 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Cycling_T|lymph-node_spleen / Manually curated celltypes from each tissue | 1.68e-06 | 197 | 128 | 7 | aca6cbff7391ff550061bb7daa67fc5f6585806a | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.68e-06 | 197 | 128 | 7 | 47be19f595135da248469b2e21b8d88f561827b2 | |
| ToppCell | (4)_B_cells-(4)_B_Hypermutation|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.73e-06 | 198 | 128 | 7 | 8be724a49b4c911d68c3e82fb75e96722d0eaa03 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for bronchial biopsy | 1.73e-06 | 198 | 128 | 7 | d5306121a75c5eb37d62c353799a98e6ba5ab63f | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 1.73e-06 | 198 | 128 | 7 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.73e-06 | 198 | 128 | 7 | ed86b0247006befe55400c287d334d2202b470bd | |
| Computational | Neighborhood of H2AFX | 5.08e-05 | 31 | 72 | 4 | GNF2_H2AFX | |
| Computational | Neighborhood of CENPF | 5.63e-05 | 62 | 72 | 5 | GNF2_CENPF | |
| Computational | Neighborhood of SMC2L1 | 6.54e-05 | 33 | 72 | 4 | GNF2_SMC2L1 | |
| Computational | Neighborhood of HMMR | 2.66e-04 | 47 | 72 | 4 | GNF2_HMMR | |
| Computational | Neighborhood of RRM1 | 2.98e-04 | 88 | 72 | 5 | GNF2_RRM1 | |
| Computational | Neighborhood of CKS2 | 3.38e-04 | 50 | 72 | 4 | GNF2_CKS2 | |
| Computational | Neighborhood of CDC20 | 5.23e-04 | 56 | 72 | 4 | GNF2_CDC20 | |
| Computational | Neighborhood of FEN1 | 5.23e-04 | 56 | 72 | 4 | GNF2_FEN1 | |
| Computational | Neighborhood of CCNB2 | 5.59e-04 | 57 | 72 | 4 | GNF2_CCNB2 | |
| Computational | Neighborhood of CDC2 | 7.70e-04 | 62 | 72 | 4 | GNF2_CDC2 | |
| Computational | Neighborhood of MKI67 | 8.37e-04 | 28 | 72 | 3 | GNF2_MKI67 | |
| Computational | Intermediate filaments and MT. | 1.09e-03 | 68 | 72 | 4 | MODULE_438 | |
| Computational | Neighborhood of CCNA2 | 1.09e-03 | 68 | 72 | 4 | GNF2_CCNA2 | |
| Computational | Neighborhood of PCNA | 1.09e-03 | 68 | 72 | 4 | GNF2_PCNA | |
| Drug | AC1L1I71 | 4.43e-06 | 79 | 123 | 6 | CID000004451 | |
| Drug | sulprofos | 5.30e-06 | 7 | 123 | 3 | CID000037125 | |
| Drug | bromfenacoum | PHACTR2 VSNL1 ANK3 PITRM1 RCN2 PIP5K1C HNRNPD MPRIP NEFL AKAP9 UBAP2L DLG4 MTUS2 HSPA9 | 1.03e-05 | 644 | 123 | 14 | ctd:C013418 |
| Disease | beta-defensin 113 measurement | 1.67e-05 | 2 | 121 | 2 | EFO_0802320 | |
| Disease | X-21258 measurement | 4.99e-05 | 3 | 121 | 2 | EFO_0800802 | |
| Disease | Alzheimer's disease (is_marker_for) | 9.51e-05 | 257 | 121 | 7 | DOID:10652 (is_marker_for) | |
| Disease | brain measurement, hippocampal volume | 2.47e-04 | 6 | 121 | 2 | EFO_0004464, EFO_0005035 | |
| Disease | Major Depressive Disorder | 5.12e-04 | 243 | 121 | 6 | C1269683 | |
| Disease | Unipolar Depression | 7.15e-04 | 259 | 121 | 6 | C0041696 | |
| Disease | susceptibility to influenza measurement | 7.35e-04 | 10 | 121 | 2 | EFO_0803537 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 7.50e-04 | 99 | 121 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | fibromuscular dysplasia | 7.88e-04 | 44 | 121 | 3 | EFO_1000938 | |
| Disease | X-11308 measurement | 8.95e-04 | 11 | 121 | 2 | EFO_0800693 | |
| Disease | Schizophrenia | 1.04e-03 | 883 | 121 | 11 | C0036341 | |
| Disease | thymol sulfate measurement | 1.07e-03 | 12 | 121 | 2 | EFO_0021170 | |
| Disease | neuroblastoma | 1.35e-03 | 116 | 121 | 4 | EFO_0000621 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 1.67e-03 | 57 | 121 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | Autosomal recessive primary microcephaly | 1.69e-03 | 15 | 121 | 2 | cv:C3711387 | |
| Disease | sickle cell anemia (is_implicated_in) | 1.93e-03 | 16 | 121 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | Intellectual Disability | 2.51e-03 | 447 | 121 | 7 | C3714756 | |
| Disease | coronary artery calcification | 2.61e-03 | 450 | 121 | 7 | EFO_0004723 | |
| Disease | Chronic myeloproliferative disorder | 2.72e-03 | 19 | 121 | 2 | C1292778 | |
| Disease | energy expenditure measurement | 3.02e-03 | 20 | 121 | 2 | EFO_0008005 | |
| Disease | Nephritis, Tubulointerstitial | 3.33e-03 | 21 | 121 | 2 | C0041349 | |
| Disease | Seckel syndrome | 3.65e-03 | 22 | 121 | 2 | C0265202 | |
| Disease | Down syndrome (is_marker_for) | 3.65e-03 | 22 | 121 | 2 | DOID:14250 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VHVTQEDFEMAVAKV | 376 | P62195 | |
| KTIIKEMAAHNELEE | 361 | Q5W0A0 | |
| ISQFTEKIEKMQELH | 2821 | Q99996 | |
| SMDKIETINFHEVKE | 131 | Q9UKF6 | |
| QSKMEDTLEHTDKEV | 1236 | Q02952 | |
| HTTMANKVETLKEEE | 181 | Q9Y3L3 | |
| IQHVEEQSKEMTVEA | 571 | Q9P2G1 | |
| VKLESIHQVMSEYKE | 211 | Q6NSI1 | |
| HKEFQDLREVMEKSS | 181 | Q53GS7 | |
| EHIFCKSVEETRMKE | 511 | O60706 | |
| TKEMEGDTQKLEVEH | 1306 | Q8N2N9 | |
| FKKEHEEFETMENVN | 831 | P51828 | |
| HELQVEMKKMESDFE | 496 | O60610 | |
| EDHIKMKQQALTEFE | 116 | Q8NB25 | |
| HVLAFQTMEEEKEKE | 751 | Q8NB25 | |
| LTQEIAMEHFVKKVE | 466 | Q9ULX6 | |
| MSTHELEKKELEENF | 1171 | Q5JR59 | |
| MTEFVIQEALEEHDK | 186 | Q14257 | |
| MKKETHVFSEADAEQ | 701 | Q6ZP01 | |
| VVDVENLFMSVHKEE | 176 | Q92830 | |
| NLFMSVHKEEDTDTK | 181 | Q92830 | |
| VTTDHSEMKKLFEEQ | 591 | Q9H3S7 | |
| HEDVTVMDTKLKIIE | 961 | Q14571 | |
| QKVESETHVTDMDFE | 1161 | Q9UPP5 | |
| ELMEVNHDDKVVTTE | 186 | Q8IZ07 | |
| HVFKVKDMENLEDVF | 451 | P00751 | |
| DHEMVASVDVSIQVK | 2786 | Q14517 | |
| KFEALDIEKAEHMET | 306 | Q6WCQ1 | |
| VVEEKTKAMDLHAVL | 331 | Q9NSY0 | |
| KLEESAVTVMFDKVQ | 191 | Q9NZL9 | |
| ANIHIYDTEKKMVEI | 231 | P30419 | |
| TEDELKEFHMKTEQL | 411 | Q9HC44 | |
| EIIFQAHIEEMNEKT | 661 | Q13439 | |
| QKEVHRVEMEELTSK | 1866 | Q13439 | |
| EEMQVKEVVEKHSQF | 116 | Q58FF8 | |
| MVVEDKKESEFHFSK | 151 | Q8NCR3 | |
| TTAENEFVMLKKDVD | 266 | P13647 | |
| KSDEMNVKVLDFEHF | 56 | P60660 | |
| LQVDFHTEMKEESDI | 36 | Q05315 | |
| FVTHEDAVAAMSKDK | 241 | P31942 | |
| DKTVVFVDNHVELEM | 966 | Q8NG31 | |
| ATFAKVEKEEDMIHF | 426 | Q6X4W1 | |
| KSHVMTKFAEEEDVR | 236 | P59047 | |
| ETHMKKSESEVEEAA | 266 | Q16643 | |
| LNEFKSTEMEVHEES | 611 | O75167 | |
| FHMFTKEELEEVIKD | 226 | P28066 | |
| FHAEKVTMVSKIVDA | 286 | Q5TGP6 | |
| EGIIHDTETKMEEFK | 586 | P38646 | |
| RKELNEFKSSEMEVH | 676 | Q8IZ21 | |
| LEIMHKEAQDIKFTE | 261 | O00425 | |
| EDESSHGVIMEKFIK | 306 | Q9GZU2 | |
| AIMTEADKVSELHQE | 86 | Q9BY11 | |
| ELNEFKSTEMEVHEL | 556 | Q9C0D0 | |
| LHAMIKAEESSKQEE | 236 | O75400 | |
| TEETTHVVMKTDAEF | 1681 | P38398 | |
| KSVLKSDEEHMEEAI | 361 | Q15884 | |
| LKKREEHMDTFIETF | 361 | Q96LB3 | |
| EHMDTFIETFEETKN | 366 | Q96LB3 | |
| LDMKKHVNEEVTEFL | 136 | Q659A1 | |
| VMKDLQKHVDDFDKV | 986 | Q6ZP82 | |
| ESDILEKVKEHQESM | 241 | P33261 | |
| SDKEVQMHFAELQEK | 1396 | P49454 | |
| MLTKNVDFVKDAHEE | 176 | O95273 | |
| ALKEEVSSHDQEMDK | 766 | Q0VF96 | |
| DEEENEHLKKTVTML | 191 | Q01850 | |
| SIFNIEMVKEKTAEE | 146 | Q5TC12 | |
| EVVTMHEEKQESAIF | 126 | Q01740 | |
| KETLAEQHKEAMAVF | 76 | Q6ZRK6 | |
| EAKEEFAHKTLAMDV | 641 | P51795 | |
| HKESKMTIFEKENFI | 121 | P05813 | |
| METTISEIHVENKDE | 1 | P24588 | |
| AHFVDVIKEDSLMKD | 726 | O60503 | |
| VKAFQMKASSEEDDH | 2216 | Q12955 | |
| EQEISKFKECHSMLD | 86 | Q9UL45 | |
| HFVSSREKMEKDIQA | 581 | P78352 | |
| LMKKFVEDTKNEVHE | 171 | O75828 | |
| DKVLDMEVVHKELTN | 516 | Q9NYP3 | |
| EKSIEDMTEEAFQKH | 871 | P14735 | |
| MEKEKHNQPSEFTIE | 271 | P11712 | |
| VTKVNETEMDIAKHS | 156 | O75629 | |
| LAMETLQEKSQHKEE | 436 | Q4V328 | |
| VQTELLKEHMAKEEV | 196 | Q96LJ7 | |
| SLVVEHFKDDVEVVM | 2711 | Q8IVF4 | |
| SHITAEFEIETKMEE | 546 | Q8IWY4 | |
| ELKNKELTLEHMETE | 1166 | Q02224 | |
| IEDDRKTLMTKHFQE | 131 | Q96PB7 | |
| EKETHAAFMEEVKSR | 141 | Q13474 | |
| SFDSHEAAKKAVEEM | 236 | P0CB38 | |
| IMLADKHAKEIEEES | 56 | Q9BTC8 | |
| KESESVDKVMDQKEH | 146 | Q14103 | |
| DHVQFAEFKIDMDSK | 791 | Q6PCB5 | |
| HSEENMDKTILVKNE | 521 | Q9GZV3 | |
| FDHKTLEEQMGKIEN | 1686 | O75691 | |
| GEFLKIKHIVMDETE | 651 | P0C7P3 | |
| IKHIVMDETENFCSK | 656 | P0C7P3 | |
| YMLNEEETTEHQKVK | 481 | Q4G0N8 | |
| EAEKIMLSFHEEQEV | 816 | O60502 | |
| EKKQDVDESLTMHFS | 296 | Q8NE09 | |
| IDHFTKDITMKNLVE | 131 | O15539 | |
| KEDLESENLSDMVHK | 351 | Q9NSI8 | |
| SDDEFIIKTVMHKEA | 181 | O60331 | |
| EEHFKVLVKMTAQEL | 696 | Q5JRX3 | |
| KQIMEEAVTRKFVHE | 21 | O43147 | |
| KMHKFEDIETVDILA | 251 | Q6AI14 | |
| KLEEFQKISHMVIEE | 51 | A0MZ66 | |
| VDMEHFKVIKTHQIE | 316 | Q8TE99 | |
| HEVFENSSKIVIVME | 116 | Q9H093 | |
| EFTQKMAKISHLETE | 131 | Q6PIF2 | |
| VVEKKNIIEATHMYD | 941 | Q9NRY4 | |
| KSMEKHIEEDEVRSS | 96 | Q13277 | |
| IHFMEEIDKEISEMK | 136 | P59998 | |
| IFKEMQSVVDARHDK | 66 | Q5U649 | |
| QVLEHESEKVKEMNT | 421 | A6NNY8 | |
| MHSLKKVTFEDVAID | 1 | Q6ZN79 | |
| EVMEDLVKSTEFNEH | 11 | P62760 | |
| MDTDVVKLIESKHEV | 11 | P62256 | |
| MISDHNDADFEEKVK | 41 | Q14157 | |
| EVLKIHVLEDMNEFT | 141 | Q13156 | |
| LHKETKKVFSDVMED | 86 | P23921 | |
| ADLQKEEHVVMEEKT | 1476 | Q9HCK1 | |
| EMETQKEKIHEDTKE | 336 | Q9NTJ3 | |
| EESDKEKQEMFAVHS | 3346 | Q709C8 | |
| MHSLKKVTFEDVAID | 1 | A8MWA4 | |
| STLHKSVVKMEEELQ | 481 | Q9BZW7 | |
| IDTKNEIEEKMSHFQ | 296 | Q8NEG5 | |
| MHSLEKVTFEDVAID | 1 | P0CI00 | |
| MHSLEKVTFEDVAID | 1 | P0CH99 | |
| HRETKEMFCEVDKSL | 96 | A0A3B3IT33 | |
| HKQETHTMEAVKLVE | 226 | O95363 | |
| DIDKENEMLVTVAHF | 981 | Q93009 | |
| MNFKDLIETKAEEHN | 771 | Q9UBB9 | |
| QTKFDKVVMEFLHEC | 346 | Q5BKZ1 | |
| HKTSSNDKMELFEVD | 141 | Q8WU03 | |
| KMVDASKSIEAVHED | 176 | P23919 | |
| FLVDSINKAMEKDHE | 366 | Q12965 | |
| LMDEISFLKKVHEEE | 216 | P07196 |